Friday, July 30, 2010

Novo Nordisk, Lilly, Novartis Said to Bid for Ascendis Pharma - Bloomberg

Ascendis has a technology that allows drugs to be released into the body in a controlled way over time, according to its website. The company focuses on hormone-related disorders and is developing a human growth hormone that can be taken once a week. It’s also developing new formulations of approved medicines and products for central nervous system and infectious diseases, according to the website.

Posted via email from Jack's posterous

No comments: